SG10201907542SA - Active substances of bifidobacterium lactis gkk2, composition comprising the same and method of promoting longevity using the same - Google Patents

Active substances of bifidobacterium lactis gkk2, composition comprising the same and method of promoting longevity using the same

Info

Publication number
SG10201907542SA
SG10201907542SA SG10201907542SA SG10201907542SA SG10201907542SA SG 10201907542S A SG10201907542S A SG 10201907542SA SG 10201907542S A SG10201907542S A SG 10201907542SA SG 10201907542S A SG10201907542S A SG 10201907542SA SG 10201907542S A SG10201907542S A SG 10201907542SA
Authority
SG
Singapore
Prior art keywords
same
composition
active substances
bifidobacterium lactis
promoting longevity
Prior art date
Application number
SG10201907542SA
Inventor
Chen Chin-Chu
Chen Yen-Lien
Lin Shih-Wei
Chen Yen-Po
WANG Ci-Sian
Hou Yu-Hsin
SHIH Yang-Tzu
Lin Ching-Wen
Chen Ya-Jyun
Jiang Jia-Lin
Original Assignee
Grape King Bio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grape King Bio Ltd filed Critical Grape King Bio Ltd
Publication of SG10201907542SA publication Critical patent/SG10201907542SA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • A23V2400/531Lactis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
SG10201907542SA 2018-08-16 2019-08-16 Active substances of bifidobacterium lactis gkk2, composition comprising the same and method of promoting longevity using the same SG10201907542SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW107128656A TWI740057B (en) 2018-08-16 2018-08-16 An active substance of bifidobacterium lactis gkk2, a composition comprising thereof and its use for promoting longevity

Publications (1)

Publication Number Publication Date
SG10201907542SA true SG10201907542SA (en) 2020-03-30

Family

ID=69523201

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201907542SA SG10201907542SA (en) 2018-08-16 2019-08-16 Active substances of bifidobacterium lactis gkk2, composition comprising the same and method of promoting longevity using the same

Country Status (6)

Country Link
US (1) US11058733B2 (en)
JP (1) JP7060555B2 (en)
CN (1) CN110835615B (en)
MY (1) MY192161A (en)
SG (1) SG10201907542SA (en)
TW (1) TWI740057B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI740199B (en) * 2019-08-30 2021-09-21 葡萄王生技股份有限公司 A composition for modulation of testosterone and its use
TWI825324B (en) * 2020-06-17 2023-12-11 國立陽明交通大學 Anti-aging uses of citrus extract ingredients
CN115025129B (en) * 2021-03-05 2024-04-19 葡萄王生技股份有限公司 Composition containing lactobacillus and use thereof for preventing and/or improving skin aging

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2816564B2 (en) * 1989-05-30 1998-10-27 日研フード株式会社 Lactic acid bacteria preparation
WO2014141265A1 (en) 2013-03-14 2014-09-18 Nofar Gil Inhibition of neurodegenerative disease by grape seed extract, green tea extract and probiotic bacteria
CN104560829B (en) * 2015-01-14 2017-11-14 贵州大学 One plant of fragrant pig source property norcholesterol, oxytolerant Bifidobacterium BZ25
CN104996992A (en) 2015-04-10 2015-10-28 劲膳美生物科技股份有限公司 Medical formula food for muscle attenuation syndromes
CN104839699A (en) 2015-04-23 2015-08-19 劲膳美生物科技股份有限公司 Heart disease non-total nutrient formula food
TWI636133B (en) 2017-10-20 2018-09-21 葡萄王生技股份有限公司 A lactobacillus plantarum, composition, culturing method and use of elimination of body fat, reduction of hepatomegaly and/or anti-inflammatory
TWI651412B (en) 2017-11-01 2019-02-21 葡萄王生技股份有限公司 Novellactobacillus paracaseigks6 for improving metabolic syndromes, its medium, incubation method, use, pharmaceutical composition and edible composition
CN108220193B (en) * 2018-01-08 2021-01-15 金华银河生物科技有限公司 Bifidobacterium lactis, bifidobacterium lactis freeze-dried powder and preparation method thereof

Also Published As

Publication number Publication date
JP7060555B2 (en) 2022-04-26
JP2020075902A (en) 2020-05-21
CN110835615A (en) 2020-02-25
US11058733B2 (en) 2021-07-13
US20200054692A1 (en) 2020-02-20
TWI740057B (en) 2021-09-21
MY192161A (en) 2022-08-03
CN110835615B (en) 2023-09-08
TW202008996A (en) 2020-03-01

Similar Documents

Publication Publication Date Title
SG10201907552TA (en) An active substance of lactobacillus paracasei gks6, a composition comprising thereof and its use for promoting longevity
IL263238A (en) Composition of probiotics and digestive enzymes and method of preparing and using the same
EP3722412A4 (en) Novel bifidobacterium bacteria and composition including novel bifidobacterium bacteria
PT3793008T (en) Positive electrode material, preparation method therefor, and use thereof
EP3733715A4 (en) Triabody, preparation method and use thereof
ZA202105317B (en) Composite material, its preparation method, and its use as electrode material
SG10201907542SA (en) Active substances of bifidobacterium lactis gkk2, composition comprising the same and method of promoting longevity using the same
EP3505195A4 (en) Regenerative medical material, preparation method therefor, and use thereof
PT3580208T (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
EP3680331A4 (en) Modified cas9 protein, and use thereof
SG10201910740UA (en) Lactobacillus fermentum gkf3, composition comprising the strain and method for improving psychataxia using the same
IL281171A (en) Cellulose-synthase-like enzymes and uses thereof
EP3636744A4 (en) Lactobacillus curvatus wikim55 having activity of promoting hair growth, and composition containing same.
ZA202103259B (en) Modified cas9 protein, and use thereof
EP3521415A4 (en) Novel lactobacillus sakei and composition comprising same
EP3812452A4 (en) Bifidobacterium lactis bl-99 and application thereof
EP4245840A4 (en) Probiotic system and use thereof
IL278036A (en) Hpk1 inhibitors, preparation method and application thereof
HUE053801T2 (en) Cathode active material and preparation method thereof
SG10201907547RA (en) An active substance of lactobacillus plantarum gkm3, a composition comprising thereof and its use for promoting longevity
SG11202103103TA (en) Gdsl lipase, genetically-engineered bacteria and application thereof
EP3639845A4 (en) Il-15 protein complex pharmaceutical composition and uses thereof
EP4039803A4 (en) Engineered human immune cells, preparation method and application thereof
GB2568843B (en) Lactobacillus plantarum proliferator, and fermented product added with the proliferator and preparation method thereof
WO2017123610A3 (en) Bacteria engineered to detoxify deleterious molecules